As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >


Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >


Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >

Genethon Research & Development Division

Genethon, 1 bis rue de l’Internationale – BP 60
91002 EVRY cedex – FRANCE
Phone : +33 1 69 47 28 79
Email :

General Manager: REVAH Frédéric
Web Site >
Genethon Laboratory Genethon Laboratory

#Genomics / Postgenomics #Biotherapies #Synthetic biology #Systems Biology

  • Rare diseases, Neuromuscular diseases
  • Immunodeficiencies
  • Muscular dystrophy
  • Gene therapy
  • Therapeutics based on genetic knowledge
  • Gene transfer products
  • Gene targeting, Gene transfer
  • Stem cells
  • Pharmaceutical development
  • Translational research

Supervisions :

CNRS - tutelle de laboratoires génopolitainsUEVE - Tutelle laboratoire génopolitain

Field of Activity

Gene therapy for rare genetic diseases.

Research, preclinical and clinical development of gene therapies for neuromuscular and other rare genetic diseases.

The Genethon R&D Division is active in three main areas:

Therapeutic programs:

  •  Identification of new therapeutic approaches for monogenic neuromuscular diseases, including Duchenne muscular dystrophy, progressive limb-girdle muscular dystrophies, X-linked myotubular myopathy and spinal muscular atrophy.
  • The research includes the investigation of physiopathological mechanisms, the identification of new biomarkers and new therapeutic strategies based on the administration of adeno-associated viral vectors. This research is carried out by the groups of Isabelle Richard, PhD (DR1 CNRS), Anna Buj-Bello, PhD (CR2 INSERM) and Fedor Svinartchouk, PhD.
  • Gene therapies for primary immunodeficiencies, including Wiskott-Aldrich syndrome, chronic granulomatous disease, and X-linked and Artemisdeficient severe combined immunodeficiencies. The research includes the development of new lentiviral vectors for the genetic modification of hematopoietic stem cells, the analysis of stem cell differentiation, and the study of the genetic and epigenetic consequences of gene transfer in the human genome. This work is performed in the INSERM Unit S951 led by Anne Galy PhD (DR1 INSERM).
  • Gene therapy of liver diseases and metabolic disorders, including Crigler-Najjar syndrome. The research includes the development of new adeno-associated viral vectors and a clinical translation strategy based on specific gene expression. This research is carried out by Federico Mingozzi (Associate Professor, Pierre and Marie Curie University).

Horizontal research activity:

  • Muscle physiology and pathology (Isabelle Richard).
  • Vector technology (Otto Merten). Innovating design, production, purification and analysis of gene transfer vectors.
  • Vector-host interactions (Anne Galy). Understanding the immune consequences of in vivo gene delivery.
  • Genome editing (Mario Amendola). Exploring the power of site-directed DNA cleavage to correct mutations or alter gene regulation.

Development for clinical applications:

  • Development of products and processes (Matthias Hebben).
  • Analytical development (Christine Le Bec).

The goal of these units is to improve the productivity, scale and robustness of the manufacturing processes, increase the quality of the vectors produced, reduce the cost per “dose”, and develop an accurate, robust and economical QC.

Processes and analytical tests are then transferred to YposKesi to be validated and implemented in the GMP production routine.
The units interact upstream with research units and downstream to the GMP manufacturing and quality control teams of YposKesi.

YposKesi produces clinical batches for clinical trials conducted in France, in Europe and in the United States.

  • Teams

    – Plate-forme Préclinique directed by Nathalie DANIELE

    – Banque d’ADN et de Cellules directed by Safaa SAKER-DELYE

    – INTEGRARE directed by Anne GALY

    – Maladies neuromusculaires associées aux myotubularines directed by Anna BUJ-BELLO

    – Dystrophies musculaires directed by Isabelle RICHARD

Genopole’s Laboratories

#Genomics / Postgenomics

In same field

LBEPS - Laboratoire genopolitain


LBEPS is a laboratory dedicated to the physiology and biology of exercise implementing a translation strategy from the physiology of humans in motion to the study of cellular, molecular, genetic and epigenetic responses to exercise and recovery

Inserm - Logo


ART-TG is a pre-GMP stage R&D laboratory aiming to bridge a gap between research and clinical or industrial applications. It has pharmaceutical expertise for product development and product manufacturing, specifically for genomic therapy approaches.

I-Stem - laboratoire génopolitain


The institute evaluates the therapeutic potential of all types of stem cells in the setting of monogenic diseases.



Research at LGRK focuses on the homeostasis, regenerative potential and radiosensitivity of human epidermal stem cells.

Integrare - Genopole's Laboratory


The Integrare research unit aims to develop effective and safe gene therapies for rare genetic diseases such as neuromuscular disorders, metabolic diseases or blood/immune disorders

Genoscope - CNS - Genopole's laboratory

Genoscope – CNS

Genomics and postgenomics of biodiversity – Metagenomics of microorganisms from the environment.

Genoscope - CNS - Genopole's laboratory

Genomics Metabolics

The Metabolic Genomics UMR is the fundamental research structure of Genoscope – National Sequencing Center – Study of the chemistry and the diversity of organisms. Genomics of eukaryotes, prokaryotes and metagenomes.

GenHotel European Research Laboratory For Rheumatoid Arthritis - Genopole's laboratory


Genomics – Genetic Statistics Research on genetic susceptibility to complex diseases through genomic analyses with a focus on rheumatoid arthritis.



Plant genomics. Detection, analysis and management of plant species polymorphism.

CNRGH / CEA / François Jacob Institut


The CNRGH is a national-level center whose mission is to provide high throughput genotyping and sequencing services with the objective of optimizing genetic and genomic research for human diseases.

View all >
With the support from
Région île de France